Home Members Tools Credit Cards
   

VSCI Stock Quote and Technical Analysis

Portfolios Markets Resources
  Symbol List
Vision-Sciences, Inc. (VSCI)
▼ 0.97 (-0.02) -2.02%
Open: 0.9629
High: 1.08
Low: 0.96
Afterhours: N/A - N/A
Volume: 17055
6/18/2013 3:59pm
 
Interactive Chart
EPS: -0.23 (Current Year Estimated: -0.21)
Dividend: N/A
P/E: N/A

Technicals:
52 Week Range: 0.89 - 1.70
50 Day Moving Average: 1.0289
200 Day Moving Average: 1.07
Pivot Point (Next Trading Session): 1

Login or signup free to Add "VSCI" to your portfolio

Resources:

News:


VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ
Tue, 18 Jun 2013 14:31:02 GMT


VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Thu, 16 May 2013 14:25:07 GMT


VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ
Wed, 15 May 2013 03:08:33 GMT


Vision Sciences appoints Howard Zauberman as interim CEO
Mon, 13 May 2013 21:10:52 GMT


Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
Mon, 13 May 2013 21:01:49 GMT
[GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that Howard ...

Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript
Tue, 30 Apr 2013 14:19:04 GMT
[at Seeking Alpha] - Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript

VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
Tue, 30 Apr 2013 03:20:57 GMT


Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013
Mon, 29 Apr 2013 22:10:06 GMT
[at noodls] - April 29, 2013 Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. ...

Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013
Mon, 29 Apr 2013 21:30:00 GMT
[GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced financial results ...

Q4 2013 Vision Sciences Inc Earnings Release - After Market Close
Mon, 29 Apr 2013 11:07:06 GMT


Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results
Tue, 23 Apr 2013 22:06:07 GMT
[at noodls] - April 23, 2013 Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading ...

Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results
Tue, 23 Apr 2013 21:18:56 GMT
[GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company ...

Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System
Tue, 19 Mar 2013 16:09:38 GMT
[at noodls] - March 18, 2013 The 7000 Series Vision System(R) Offers Imaging, Video/Audio Archiving, and Workflow Features in One Platform ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ...

Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System
Mon, 18 Mar 2013 20:05:00 GMT
[GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced the launch of ...

Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors
Wed, 13 Mar 2013 14:55:49 GMT
[at noodls] - March 12, 2013 ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ...

VISION SCIENCES INC /DE/ Files SEC form 8-K, Financial Statements and Exhibits
Wed, 13 Mar 2013 12:49:51 GMT


Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference
Wed, 06 Mar 2013 21:58:05 GMT
[at noodls] - March 6, 2013 ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ...

Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
Thu, 07 Feb 2013 20:22:13 GMT
[at noodls] - February 7, 2013 Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ...

VISION SCIENCES INC /DE/ Financials
Fri, 01 Feb 2013 18:04:24 GMT


VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report
Tue, 29 Jan 2013 15:35:42 GMT


All Company News is Powered by Yahoo! Finance

 

 

 

Credit Cards | Finance Social Network | Credit Card Reviews | Markets
About | FG on the Web | Sitemap | Privacy | Terms | Contact | Print


Copyright © 2013 Finance Globe. All rights reserved.